Kira Sheinerman, PhD, is the co-founder and executive director of DiamiR Biosciences, a private molecular diagnostics company focused on brain health. Dr. Sheinerman is a Managing Director of Investment Banking at H.C. Wainwright, where she works on financial and strategic transactions for growth life sciences companies, and the senior strategic consultant to Aptorum Group. Previously, Dr. Sheinerman was a Managing Director of Healthcare Investment Banking at Rodman & Renshaw, and prior to that worked at The Arcus Group, a life sciences focused boutique consulting firm. From 2010 to 2021 she served as a board member of the Boyce Thompson Institute, an affiliate of Cornell University, and from 2015 through 2018 she served as the co-chair of Alzheimer’s Association Business Consortium. Dr. Sheinerman received her PhD in Biomedical Sciences from Mount Sinai School of Medicine for her work on molecular mechanisms of Alzheimer’s Disease. Dr. Sheinerman also holds an Honors MBA from the Zicklin School of Business, Baruch College/CUNY.